For the Inventor, By the Inventor

Enter assignee name

Brisbane, CA, United States of America

Cellegy Pharmaceuticals Inc.

Calculating rank

USPTO Granted Patents = 19

% Expired Patents = 36.8

Forward Citations = 614

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Stephen Grayson (7 out of 7 patents)

Carl R Thornfeldt (7 out of 19 patents)

Thomas P Parks (4 out of 9 patents)

4. Vivien H W Mak (4 out of 5 patents)

5. Peter Michael Elias (4 out of 18 patents)

6. Michael A Adams (3 out of 26 patents)

7. Jeremy P W Heaton (3 out of 19 patents)

8. Charles E Lee (3 out of 6 patents)

9. Jung-Chung Lee (3 out of 9 patents)

10. Don R Baker (2 out of 137 patents)

11. Vivien Mak (2 out of 3 patents)

12. Lynne-Marie Postovit (1 out of 5 patents)

13. Charles H Graham (1 out of 4 patents)

14. Donald H Maurice (1 out of 1 patent)

15. Kenneth R Feingold (1 out of 8 patents)

19 patents: Sort by Forward Citations

1. 7157097 - Penetration enhancing and irritation reducing systems (2007-01-02),

2. 6987129 - Compounds and methods for the treatment of urogenital disorders (2006-01-17),

3. 6946484 - Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype (2005-09-20),

4. 6889875 - Taper well meter dose pump (2005-05-10),

5. 6869961 - Store operated calcium influx inhibitors and methods of use (2005-03-22),

6. 6787553 - Methods for remodeling neuronal and cardiovascular pathways (2004-09-07),

7. 6747063 - Combination therapy for treatment of erectile dysfunction (2004-06-08),

8. 6699886 - Store operated calcium influx inhibitors and methods of use (2004-03-02),

9. 6627632 - Compositions and methods for the treatment of anorectal disorders (2003-09-30),

10. 6579865 - Penetration enhancing and irritation reducing systems (2003-06-17),

11. 6482839 - Pyridine-thiols for treatment of a follicular dermatosis (2002-11-19),

12. 6395736 - Compositions and methods for the treatment of anorectal disorders (2002-05-28),

13. 6319913 - Penetration enhancing and irritation reducing systems (2001-11-20),

14. 6071543 - Pyridine-thiols reverse mucocutaneous aging (2000-06-06),

15. 6010691 - Methods for enhancing permeation of a topically administered (2000-01-04),

Company Overview

Cellegy Pharmaceuticals Inc. is a biopharmaceutical company based in Brisbane, California, focused on developing innovative therapies for various medical conditions. The company specializes in drug delivery systems and formulations, particularly in the fields of dermatology and urology. Cellegy is dedicated to advancing its proprietary technologies to enhance patient outcomes and improve treatment efficacy. Through its research initiatives, the company aims to address unmet medical needs and contribute to the evolving landscape of pharmaceutical solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

19 Patents

#7 in Brisbane, CA

#4,108 in California

#17,154 in US

#32,705 in the World

Brisbane, CA, United States of America

Cellegy Pharmaceuticals Inc.

Forward Citations = 614

15 inventors:

Stephen Grayson (7 out of 7 patents)

Carl R Thornfeldt (7 out of 19 patents)

Thomas P Parks (4 out of 9 patents)

4. Vivien H W Mak (4 out of 5 patents)

5. Peter Michael Elias (4 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellegy Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/cellegy-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…